Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 356 results for "Victoza"

Opinion/decision on a Paediatric Investigation Plan (PIP): ...

Place, Canary Wharf, London E14 5EU, United Kingdom . Tel. +44 (0)20 3660 6000 . Fax +44 European Medicines Agency, 1 month ago

14 images for Victoza

Pharma Letter, 2 months ago
diaTribe, 2 months ago
diaTribe, 2 months ago
diaTribe, 2 months ago
diaTribe, 2 months ago
diaTribe, 2 months ago
diaTribe, 2 months ago
diaTribe, 2 months ago
diaTribe, 2 months ago
diaTribe, 2 months ago

Human medicines European public assessment report (EPAR): Victoza, liraglutide, Revision: 11, Authorised

This is a summary of the European public assessment report (EPAR) for Victoza. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency1 month ago Liraglutide Gets Okay From EU for Obesity  RxList2 months ago European Medicines Agency Release: Novo Nordisk A/S (NVO)'s Saxenda Recommended For Approval In Weight Management In Adults 1/23/2015  ClinicSpace2 months ago Novo Nordisk gets positive opinion for Saxenda from EMA's CHMP  Pharma Letter2 months ago

Novo Nordisk Fourth-Quarter Profit Beats Expectations on Victoza

(Bloomberg) -- Novo Nordisk A/S, the world's largest insulin maker, reported an 8 percent increase in fourth-quarter profit, helped by currency swings and higher sales of its Victoza and Levemir diabetes therapies. Net income climbed to 6.53 ...
 Washington Post2 months ago Novo Nordisk Fourth-Quarter Net Beats Estimates on Victoza  Washington Post2 months ago Novo Nordisk Posts Higher Profit  Benzinga.com2 months ago Novo Nordisk Forecasts 2015 Earnings to Advance on Currencies  Washington Post2 months ago

Novo Nordisk launches Victoza diabetes drug

WITH more than 387 million people 8.3 per cent of the global adult population believed to have diabetes worldwide, and additional 316 million people (6.9 per cent of the world adult population) having impaired glucose tolerance (IGT), which can ...
 The Guardian Nigeria2 months ago Novo Nordisk Launches Vicotza Diabetes Drug  AllAfrica.com2 months ago Novo Nordisk A/S : Launches Vicotza Diabetes Drug  4 Traders2 months ago

Novo Nordisk increased operating profit in local currencies by 13% in 2014

Comments January 30, 2015 - London Sales growth of 8% in local currencies driven by growth in sales of Levemir® and Victoza® Sales increased by 8% in local currencies and by 6% in Danish kroner to 88.8 billion. Sales of modern and ...
 AndhraNews.net2 months ago REG-Novo Nordisk increased operating profit in local currencies by 13% in 2014  Reuters2 months ago Novo Nordisk A/S : increased operating profit in local currencies by 13% in 2014  4 Traders2 months ago Profits for Novo Nordisk in 2014  Nordic Life Science1 month ago

Novo Nordisk's Victoza Tops List of Drug Payments to Physicians

Novo Nordisk paid more than $9 million to physicians for promotion of its diabetes drug Victoza in the last five months of 2013, topping the list of drugs that were responsible for the most physician payments during the first reporting period ...
 FDA News4 weeks ago

Victoza powers Novo's strong year; CEO projects growth for 2015

Novo Nordisk ($NVO) CEO Lars Sørensen today told investors that 2014 had been a more challenging year than most, then rolled off a series of results that showed significant leaps in sales both in the U.S. and worldwide. He then waved off any ...
 FiercePharma2 months ago

A Trial on the Effect of Combining Victoza and Invokana on Glycemic Control in Type 2 Diabetes

Clinical Trial Identifier: NCT02324842 This four-month trial is testing the effect of combining Victoza (liraglutide) and Invokana (canagliflozin) on several outcomes, including A1c and the liver's production of glucose in people with type 2 ...
 diaTribe2 months ago

EC Grants Extension to Victoza

Frankfurt, Germany BIO-Europe , November 3-5, Frankfurt, Germany European Statistical Forum , November 17, Brussels, Belgium SwedenBIO CEO Summit , December 3, Stockholm, Sweden Biotech Showcase 2015 , January 12-14, San Fransisco, CA, ...
 Nordic Life Science2 months ago
Pharma Letter

Novo Nordisk's Victoza granted label extension in the UK

A license extension has been granted in the UK for Victoza (liraglutide), an already blockbuster diabetes drug from Danish insulin giant Novo Nordisk (NOV: N). The once-daily injection has been approved for adults with type 2 diabetes and ...
 Pharma Letter2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Victoza
Get updated on latest news & your favorite topics right in your inbox!
More     Less